2022-2030 Global and Regional mRNA Therapy Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version

Table Of Contents

Chapter 1 Industry Overview

1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2030)
1.4.2 East Asia Market States and Outlook (2022-2030)
1.4.3 Europe Market States and Outlook (2022-2030)
1.4.4 South Asia Market States and Outlook (2022-2030)
1.4.5 Southeast Asia Market States and Outlook (2022-2030)
1.4.6 Middle East Market States and Outlook (2022-2030)
1.4.7 Africa Market States and Outlook (2022-2030)
1.4.8 Oceania Market States and Outlook (2022-2030)
1.4.9 South America Market States and Outlook (2022-2030)
1.5 Global mRNA Therapy Market Size Analysis from 2022 to 2030
1.5.1 Global mRNA Therapy Market Size Analysis from 2022 to 2030 by Consumption Volume
1.5.2 Global mRNA Therapy Market Size Analysis from 2022 to 2030 by Value
1.5.3 Global mRNA Therapy Price Trends Analysis from 2022 to 2030
1.6 COVID-19 Outbreak: mRNA Therapy Industry Impact
Chapter 2 Global mRNA Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global mRNA Therapy (Volume and Value) by Type
2.1.1 Global mRNA Therapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global mRNA Therapy Revenue and Market Share by Type (2017-2022)
2.2 Global mRNA Therapy (Volume and Value) by Application
2.2.1 Global mRNA Therapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global mRNA Therapy Revenue and Market Share by Application (2017-2022)
2.3 Global mRNA Therapy (Volume and Value) by Regions
2.3.1 Global mRNA Therapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global mRNA Therapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global mRNA Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global mRNA Therapy Consumption by Regions (2017-2022)
4.2 North America mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America mRNA Therapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America mRNA Therapy Market Analysis
5.1 North America mRNA Therapy Consumption and Value Analysis
5.1.1 North America mRNA Therapy Market Under COVID-19
5.2 North America mRNA Therapy Consumption Volume by Types
5.3 North America mRNA Therapy Consumption Structure by Application
5.4 North America mRNA Therapy Consumption by Top Countries
5.4.1 United States mRNA Therapy Consumption Volume from 2016 to 2021
5.4.2 Canada mRNA Therapy Consumption Volume from 2016 to 2021
5.4.3 Mexico mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 6 East Asia mRNA Therapy Market Analysis
6.1 East Asia mRNA Therapy Consumption and Value Analysis
6.1.1 East Asia mRNA Therapy Market Under COVID-19
6.2 East Asia mRNA Therapy Consumption Volume by Types
6.3 East Asia mRNA Therapy Consumption Structure by Application
6.4 East Asia mRNA Therapy Consumption by Top Countries
6.4.1 China mRNA Therapy Consumption Volume from 2016 to 2021
6.4.2 Japan mRNA Therapy Consumption Volume from 2016 to 2021
6.4.3 South Korea mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 7 Europe mRNA Therapy Market Analysis
7.1 Europe mRNA Therapy Consumption and Value Analysis
7.1.1 Europe mRNA Therapy Market Under COVID-19
7.2 Europe mRNA Therapy Consumption Volume by Types
7.3 Europe mRNA Therapy Consumption Structure by Application
7.4 Europe mRNA Therapy Consumption by Top Countries
7.4.1 Germany mRNA Therapy Consumption Volume from 2016 to 2021
7.4.2 UK mRNA Therapy Consumption Volume from 2016 to 2021
7.4.3 France mRNA Therapy Consumption Volume from 2016 to 2021
7.4.4 Italy mRNA Therapy Consumption Volume from 2016 to 2021
7.4.5 Russia mRNA Therapy Consumption Volume from 2016 to 2021
7.4.6 Spain mRNA Therapy Consumption Volume from 2016 to 2021
7.4.7 Netherlands mRNA Therapy Consumption Volume from 2016 to 2021
7.4.8 Switzerland mRNA Therapy Consumption Volume from 2016 to 2021
7.4.9 Poland mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 8 South Asia mRNA Therapy Market Analysis
8.1 South Asia mRNA Therapy Consumption and Value Analysis
8.1.1 South Asia mRNA Therapy Market Under COVID-19
8.2 South Asia mRNA Therapy Consumption Volume by Types
8.3 South Asia mRNA Therapy Consumption Structure by Application
8.4 South Asia mRNA Therapy Consumption by Top Countries
8.4.1 India mRNA Therapy Consumption Volume from 2016 to 2021
8.4.2 Pakistan mRNA Therapy Consumption Volume from 2016 to 2021
8.4.3 Bangladesh mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia mRNA Therapy Market Analysis
9.1 Southeast Asia mRNA Therapy Consumption and Value Analysis
9.1.1 Southeast Asia mRNA Therapy Market Under COVID-19
9.2 Southeast Asia mRNA Therapy Consumption Volume by Types
9.3 Southeast Asia mRNA Therapy Consumption Structure by Application
9.4 Southeast Asia mRNA Therapy Consumption by Top Countries
9.4.1 Indonesia mRNA Therapy Consumption Volume from 2016 to 2021
9.4.2 Thailand mRNA Therapy Consumption Volume from 2016 to 2021
9.4.3 Singapore mRNA Therapy Consumption Volume from 2016 to 2021
9.4.4 Malaysia mRNA Therapy Consumption Volume from 2016 to 2021
9.4.5 Philippines mRNA Therapy Consumption Volume from 2016 to 2021
9.4.6 Vietnam mRNA Therapy Consumption Volume from 2016 to 2021
9.4.7 Myanmar mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 10 Middle East mRNA Therapy Market Analysis
10.1 Middle East mRNA Therapy Consumption and Value Analysis
10.1.1 Middle East mRNA Therapy Market Under COVID-19
10.2 Middle East mRNA Therapy Consumption Volume by Types
10.3 Middle East mRNA Therapy Consumption Structure by Application
10.4 Middle East mRNA Therapy Consumption by Top Countries
10.4.1 Turkey mRNA Therapy Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia mRNA Therapy Consumption Volume from 2016 to 2021
10.4.3 Iran mRNA Therapy Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates mRNA Therapy Consumption Volume from 2016 to 2021
10.4.5 Israel mRNA Therapy Consumption Volume from 2016 to 2021
10.4.6 Iraq mRNA Therapy Consumption Volume from 2016 to 2021
10.4.7 Qatar mRNA Therapy Consumption Volume from 2016 to 2021
10.4.8 Kuwait mRNA Therapy Consumption Volume from 2016 to 2021
10.4.9 Oman mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 11 Africa mRNA Therapy Market Analysis
11.1 Africa mRNA Therapy Consumption and Value Analysis
11.1.1 Africa mRNA Therapy Market Under COVID-19
11.2 Africa mRNA Therapy Consumption Volume by Types
11.3 Africa mRNA Therapy Consumption Structure by Application
11.4 Africa mRNA Therapy Consumption by Top Countries
11.4.1 Nigeria mRNA Therapy Consumption Volume from 2016 to 2021
11.4.2 South Africa mRNA Therapy Consumption Volume from 2016 to 2021
11.4.3 Egypt mRNA Therapy Consumption Volume from 2016 to 2021
11.4.4 Algeria mRNA Therapy Consumption Volume from 2016 to 2021
11.4.5 Morocco mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 12 Oceania mRNA Therapy Market Analysis
12.1 Oceania mRNA Therapy Consumption and Value Analysis
12.2 Oceania mRNA Therapy Consumption Volume by Types
12.3 Oceania mRNA Therapy Consumption Structure by Application
12.4 Oceania mRNA Therapy Consumption by Top Countries
12.4.1 Australia mRNA Therapy Consumption Volume from 2016 to 2021
12.4.2 New Zealand mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 13 South America mRNA Therapy Market Analysis
13.1 South America mRNA Therapy Consumption and Value Analysis
13.1.1 South America mRNA Therapy Market Under COVID-19
13.2 South America mRNA Therapy Consumption Volume by Types
13.3 South America mRNA Therapy Consumption Structure by Application
13.4 South America mRNA Therapy Consumption Volume by Major Countries
13.4.1 Brazil mRNA Therapy Consumption Volume from 2016 to 2021
13.4.2 Argentina mRNA Therapy Consumption Volume from 2016 to 2021
13.4.3 Columbia mRNA Therapy Consumption Volume from 2016 to 2021
13.4.4 Chile mRNA Therapy Consumption Volume from 2016 to 2021
13.4.5 Venezuela mRNA Therapy Consumption Volume from 2016 to 2021
13.4.6 Peru mRNA Therapy Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico mRNA Therapy Consumption Volume from 2016 to 2021
13.4.8 Ecuador mRNA Therapy Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in mRNA Therapy Business
14.1 Moderna
14.1.1 Moderna Company Profile
14.1.2 Moderna mRNA Therapy Product Specification
14.1.3 Moderna mRNA Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 BioNTech
14.2.1 BioNTech Company Profile
14.2.2 BioNTech mRNA Therapy Product Specification
14.2.3 BioNTech mRNA Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Pfizer
14.3.1 Pfizer Company Profile
14.3.2 Pfizer mRNA Therapy Product Specification
14.3.3 Pfizer mRNA Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Arcturus Therapeutics Holdings Inc.
14.4.1 Arcturus Therapeutics Holdings Inc. Company Profile
14.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Specification
14.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Astrazeneca
14.5.1 Astrazeneca Company Profile
14.5.2 Astrazeneca mRNA Therapy Product Specification
14.5.3 Astrazeneca mRNA Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 CureVac
14.6.1 CureVac Company Profile
14.6.2 CureVac mRNA Therapy Product Specification
14.6.3 CureVac mRNA Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global mRNA Therapy Market Forecast (2022-2030)
15.1 Global mRNA Therapy Consumption Volume, Revenue and Price Forecast (2022-2030)
15.1.1 Global mRNA Therapy Consumption Volume and Growth Rate Forecast (2022-2030)
15.1.2 Global mRNA Therapy Value and Growth Rate Forecast (2022-2030)
15.2 Global mRNA Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2030)
15.2.1 Global mRNA Therapy Consumption Volume and Growth Rate Forecast by Regions (2022-2030)
15.2.2 Global mRNA Therapy Value and Growth Rate Forecast by Regions (2022-2030)
15.2.3 North America mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.4 East Asia mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.5 Europe mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.6 South Asia mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.7 Southeast Asia mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.8 Middle East mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.9 Africa mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.10 Oceania mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.11 South America mRNA Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.3 Global mRNA Therapy Consumption Volume, Revenue and Price Forecast by Type (2022-2030)
15.3.1 Global mRNA Therapy Consumption Forecast by Type (2022-2030)
15.3.2 Global mRNA Therapy Revenue Forecast by Type (2022-2030)
15.3.3 Global mRNA Therapy Price Forecast by Type (2022-2030)
15.4 Global mRNA Therapy Consumption Volume Forecast by Application (2022-2030)
15.5 mRNA Therapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology